ID: ALA5089571

Max Phase: Preclinical

Molecular Formula: C19H15FN4OS

Molecular Weight: 366.42

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Cc1cn(-c2ccc(-c3csc(Nc4ccc(O)cc4)n3)cc2F)cn1

Standard InChI:  InChI=1S/C19H15FN4OS/c1-12-9-24(11-21-12)18-7-2-13(8-16(18)20)17-10-26-19(23-17)22-14-3-5-15(25)6-4-14/h2-11,25H,1H3,(H,22,23)

Standard InChI Key:  QXOJWCUHOHXXTA-UHFFFAOYSA-N

Associated Targets(Human)

Gamma-secretase 4915 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 366.42Molecular Weight (Monoisotopic): 366.0951AlogP: 4.89#Rotatable Bonds: 4
Polar Surface Area: 62.97Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.28CX Basic pKa: 5.85CX LogP: 4.52CX LogD: 4.51
Aromatic Rings: 4Heavy Atoms: 26QED Weighted: 0.50Np Likeness Score: -1.81

References

1. Bhattarai S, Liu L, Wolfe MS..  (2021)  Discovery of aryl aminothiazole γ-secretase modulators with novel effects on amyloid β-peptide production.,  54  [PMID:34767913] [10.1016/j.bmcl.2021.128446]

Source